Pogue-Geile, K., Yothers, G., Taniyama, Y., Tanaka, N., Gavin, P., Colangelo, L., . . . Paik, S. (2013). Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08. JNCI: Journal of the National Cancer Institute, 105(13), 989. https://doi.org/10.1093/jnci/djt140
Chicago Style (17th ed.) CitationPogue-Geile, Kay, et al. "Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08." JNCI: Journal of the National Cancer Institute 105, no. 13 (2013): 989. https://doi.org/10.1093/jnci/djt140.
MLA (9th ed.) CitationPogue-Geile, Kay, et al. "Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08." JNCI: Journal of the National Cancer Institute, vol. 105, no. 13, 2013, p. 989, https://doi.org/10.1093/jnci/djt140.